Invention Grant
- Patent Title: Modulators of IRF4 expression
-
Application No.: US16977260Application Date: 2019-03-01
-
Publication No.: US11241451B2Publication Date: 2022-02-08
- Inventor: Tianyuan Zhou , Youngsoo Kim , Robert MacLeod , Huynh-Hoa Bui , Susan M. Freier
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2019/020201 WO 20190301
- International Announcement: WO2019/169219 WO 20190906
- Main IPC: C12N15/11
- IPC: C12N15/11 ; A61K31/7125
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting IRF4 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with IRF4.
Public/Granted literature
- US20210038631A1 MODULATORS OF IRF4 EXPRESSION Public/Granted day:2021-02-11
Information query
IPC分类:
